Details for New Drug Application (NDA): 202077
✉ Email this page to a colleague
The generic ingredient in LATANOPROST is latanoprost. There are twenty drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the latanoprost profile page.
Summary for 202077
Tradename: | LATANOPROST |
Applicant: | Ryan Labs |
Ingredient: | latanoprost |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION/DROPS;OPHTHALMIC | Strength | 0.005% | ||||
Approval Date: | Feb 11, 2013 | TE: | AT | RLD: | No |
Complete Access Available with Subscription